Universität des Saarlandes
3 clinical trials · 3 recruiting · OTHER
Trials by Universität des Saarlandes
RECRUITINGPhase 3NCT07026474
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1)...
Prospective, open-label, randomized controlled phase III trail that aims to investigate whether Re-Radiochemotherapy (Re-RCT) and sequential immunotherapy with pembrolizumab...
Sponsor: Universität des SaarlandesEnrolling: 21418 locations
Recurrent Head and Neck Squamous Cell Carcinoma
RECRUITINGNCT04837755
CORONA in the Saarland
The CORSAAR study is an observational, prospective study to investigate the natural biology of COVID-19
Sponsor: Universität des SaarlandesEnrolling: 3001 location
Covid19
RECRUITINGNCT03923101
The Homburg Keratoconus Center (HKC)
Aim of this study is to conduct longitudinal and cross-sectional analyses about the corneal ectatic disease Keratoconus based on data obtained from Keratoconus patients in the...
Sponsor: Universität des SaarlandesEnrolling: 50001 location
Keratoconus